Summary
This business specializes in the development of programmable cells using advanced lab-on-a-chip technology and artificial intelligence. They offer a Desktop Biofoundry that enables automation of laboratory workflows through digital microfluidics, allowing for precise control over liquid handling processes. Their target market includes pharmaceutical, diagnostics, industrial biotech, and genome engineering companies looking to enhance their product development and workflow automation capabilities.
